Who owns TRAVERE THERAPEUTICS INC (TVTX?

Tip: Access positions for across all investors

Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Travere Therapeutics stock

Who bought or sold TRAVERE THERAPEUTICS INC (TVTX this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Wolverine Asset Management 45M $29M 0% Sep 2023
 View chart
D. E. Shaw & Co 41M $26M 0% Sep 2023
 View chart
Braidwell 28M $18M 0% Sep 2023
 View chart
Highbridge Capital Management 27M $17M 279% Sep 2023
 View chart
UBS O'Connor 25M $16M 0% Sep 2023
 View chart
Lazard Asset Management 24M $16M -13% Sep 2023
 View chart
Capstone Investment Advisors 23M $15M -47% Sep 2023
 View chart
Aviva 23M $15M 28% Sep 2023
 View chart
Citigroup 20M $13M 33% Sep 2023
 View chart
Silverback Asset Management 13M $8.1B 100% Sep 2023
 View chart
Segantii Capital Management 7.5M $4.9M -6% Sep 2023
 View chart
Morgan Stanley 3.1M $2.0M 93% Sep 2023
 View chart
Readystate Asset Management 3.0M $1.9M -67% Sep 2023
 View chart
Jane Street 2.7M $1.8M -13% Sep 2023
 View chart
Point72 Asset Management 2.6M $1.7M -70% Sep 2023
 View chart
BlackRock 2.2M $1.4M 22% Sep 2023
 View chart
Linden Advisors 1.5M $963M -89% Sep 2023
 View chart
Lion Point Capital 1.0M $648k 100% Sep 2023
 View chart
Leucadia National Corporation 500k $323k 100% Sep 2023
 View chart
Caas Capital Management 500k $317k 0% Sep 2023
 View chart
Nomura Holdings 480k $4.3M -18% Sep 2023
 View chart
Jpmorgan Chase & Co 125k $81k 0% Sep 2023
 View chart
Context Capital Management 41k $27M 41% Sep 2023
 View chart

Who sold out of Travere Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Centiva Capital Jun 2023 2.5M $2.0M
Laurion Capital Management Jun 2023 1.5M $1.2M